ADXS - Ayala Pharmaceuticals, Inc.

QQQ $ 442.13 $ 1.02 (0.23 %)

DIA $ 394.52 $ -0.72 (-0.18 %)

SPY $ 520.64 $ 0.07 (0.01 %)

TLT $ 90.36 $ 0.23 (0.26 %)

GLD $ 216.56 $ -2.45 (-1.12 %)

Previous Close

$ 0.21

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.20 - $ 1.95

Volume

76,315

Average Volume

Market Cap

1.26M

Beta (5Y Monthly)

$ 16.70

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-16-2024	12-31-2023	10-K
2	11-20-2023	09-30-2023	10-Q
3	08-10-2023	06-30-2023	10-Q
4	05-23-2023	03-31-2023	10-Q
5	02-10-2023	10-31-2022	10-K
6	09-12-2022	07-31-2022	10-Q
7	06-08-2022	04-30-2022	10-Q
8	03-17-2022	01-31-2022	10-Q
9	02-14-2022	10-31-2021	10-K
10	09-10-2021	07-31-2021	10-Q
11	06-14-2021	04-30-2021	10-Q
12	03-16-2021	01-31-2021	10-Q
13	01-22-2021	10-31-2020	10-K
14	09-10-2020	07-31-2020	10-Q
15	06-11-2020	04-30-2020	10-Q
16	03-13-2020	01-31-2020	10-Q
17	12-20-2019	10-31-2019	10-K
18	09-09-2019	07-31-2019	10-Q
19	06-10-2019	04-30-2019	10-Q
20	03-12-2019	01-31-2019	10-Q
21	01-11-2019	10-31-2018	10-K
22	09-10-2018	07-31-2018	10-Q
23	06-07-2018	04-30-2018	10-Q
24	03-12-2018	01-31-2018	10-Q
25	12-21-2017	10-31-2017	10-K
26	09-11-2017	07-31-2017	10-Q
27	06-06-2017	04-30-2017	10-Q
28	03-10-2017	01-31-2017	10-Q
29	01-09-2017	10-31-2016	10-K
30	09-08-2016	07-31-2016	10-Q
31	06-08-2016	04-30-2016	10-Q
32	02-26-2016	01-31-2016	10-Q
33	01-08-2016	10-31-2015	10-K
34	09-11-2015	07-31-2015	10-Q
35	06-15-2015	04-30-2015	10-Q
36	03-13-2015	01-31-2015	10-Q
37	01-06-2015	10-31-2014	10-K
38	09-09-2014	07-31-2014	10-Q
39	06-10-2014	04-30-2014	10-Q
40	03-17-2014	01-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Immunome Recognizes Ayala Pharmaceuticals'...
02/20/2024 13:17:43

– Immunome entered into a definitive asset purchase agreement with Ayala to acquire AL102 earlier this month –

Ladenburg Thalmann Downgrades Ayala Pharma...
11/16/2023 19:12:47

Ladenburg Thalmann analyst Ahu Demir downgrades Ayala Pharmaceuticals (OTC:ADXS) from Buy to Neutral.

Benzinga's Top Ratings Upgrades, Downgrade...
05/30/2023 15:00:38

Ladenburg Thalmann Upgrades Advaxis to Buy...
05/30/2023 11:38:09

Ladenburg Thalmann analyst Ahu Demir upgrades Advaxis (OTC:ADXS) from Neutral to Buy and announces $4 price target.

ayala-pharmaceuticals-and-advaxis-agree-to-combine-expect-uplisting-on-nasdaq

Ayala Pharmaceuticals and Advaxis Agree To...
10/19/2022 16:29:05

Ayala Pharmaceuticals Inc (NASDAQ: AYLA) and Advaxis Inc (OTC: ADXS) have announced a merger agreement.

Advaxis and Ayala Pharmaceuticals Enter in...
10/19/2022 10:33:09

Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA) (Ayala), a clinical-stage oncology company focused on developing and commercializing...

Advaxis Says Applied To List Common Stock ...
05/12/2022 21:00:53

-SEC Filing

Several Companies Highlight Upcoming Prese...
04/27/2022 14:02:45

Advaxis Highlights Presentation Of Updated...
01/11/2022 13:10:25

Updated data show a second partial response in Part B Overall response rate of 15.4% and disease control rate of 46% in Part...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
12/22/2021 21:32:04

Gainers BioCardia (NASDAQ:BCDA) shares rose 29.91% to $2.91 during Wednesday's after-market session. At the close, BioCard...

Advaxis Reports Will Explore Added Options...
12/17/2021 13:02:55

Stockholders approved Proposal 1 in support of Biosight merger Proposal 2 reverse stock split, a condition for completing the ...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
12/10/2021 14:51:39

Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 16.75% to $2.23 during Friday's pre-market session. The mar...

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
11/30/2021 21:38:37

Gainers Lannett (NYSE:LCI) shares rose 11.61% to $1.73 during Tuesday's after-market session. The market value of their ou...

Advaxis Issues Letter, Second Video Messag...
11/24/2021 13:06:04

Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunot...

Advaxis Granted U.S. Patent #11,179,339 'C...
11/23/2021 11:39:02

View patent here

Advaxis, Inc. Issues Letter to Stockholders
11/19/2021 13:03:54

Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunot...

Independent Proxy Advisory Firm Glass Lewi...
11/18/2021 13:17:38

Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunot...

Top 10 WallStreetBets Stock Mentions In Pr...
11/12/2021 10:47:48

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
09/30/2021 20:33:15

Gainers FibroGen (NASDAQ:FGEN) stock moved upwards by 4.99% to $10.73 during Thursday's after-market session. The company...

12 Health Care Stocks Moving In Thursday's...
09/16/2021 20:47:38

Gainers